Joseph David Meserve MD
Hospital Medicine/Hospitalist, Gastroenterology
Physician
Join to view full profile
3 Richland Medical Park DrSte 120Columbia, SC 29203
Phone+1 803-434-8866
Fax+1 803-933-3049
Dr. Meserve is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Diego) Medical CenterResidency, Gastroenterology, 2016 - 2022- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2015 - 2018
Medical University of South CarolinaClass of 2015
Certifications & Licensure
SC State Medical License 2023 - 2027
CA State Medical License 2016 - 2024
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 10 citationsThe Impact of Setons on Perianal Fistula Outcomes in Patients With Crohn's Disease Treated With Anti-TNF Therapy: A Multicentre Study.Jeffrey McCurdy, Javeria Munir, Simon Parlow, Gagan Sambhi, Jacqueline Reid
Alimentary Pharmacology & Therapeutics. 2025-05-01 - 13 citationsDevelopment of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn's Disease: A Multicenter Study.Jeffrey D McCurdy, Javeria Munir, Simon Parlow, Jacqueline Reid, Russell Yanofsky
Clinical Gastroenterology and Hepatology. 2024-05-01 - 17 citationsTemporary Faecal Diversion for Refractory Perianal and/or Distal Colonic Crohn's Disease in the Biologic Era: An Updated Systematic Review with Meta-analysis.Michael Jew, Joseph Meserve, Samuel Eisenstein, Vipul Jairath, Jeffrey McCurdy
Journal of Crohn's & Colitis. 2024-03-01
Journal Articles
- Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumLeah Katta, Robert Hirten, Shannon Chang, Dana Lukin, Edward V Loftus, David Faleck, Arun Swaminath, William J Sandborn, Sashidhar Varma Sagi, Sunanda Kane, Prianka Ch..., Nature
- Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY ConsortiumGursimran Kochhar, Justin Hartke, Sashidhar Varma Sagi, Edward V Loftus, Joseph Meserve, Robert Hirten, David Faleck, Shannon Chang, Dana Lukin, Farhad Peerani, Leah K..., Nature
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
